Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma.

Auteurs : Berghmans T, Grigoriu B, Sculier JP, Meert AP
Jaar : 2018
Journal : Rev Mal Respir
Volume : 35(2)
Pagina's : 197-205